Extracorporeal Membrane Oxygenation Machine Market Projected to Reach $1,085.63 million by 2030 - Exclusive Report by 360iResearch

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

The extracorporeal membrane oxygenation (ECMO) machine, a crucial medical device, offers extended cardiac and respiratory support to patients with insufficient gas exchange capabilities, marking a significant advancement in critical care.

Metadata
Provider: 
PR NewswirePR Newswire
Retrieved on: 
Wednesday, March 13, 2024
Information
Tags: 
Temperature, Component, Growth, LivaNova, Extracorporeal membrane oxygenation, Getinge Group, Intelligence, Fresenius Medical Care, Incidence, COVID-19, Patient, Pulmonary hypertension, Research, Cannula, Meconium aspiration syndrome, Carbon, ECMO, Heart, Arteriovenous, Periodic breathing, Workforce, Blood, Hemolysis, Medtronic, Nursing care plan, PPHN, Table, Ageing, Medical device
Geotags: 
UNITED STATES OF AMERICA, UNITED KINGDOM, INDIA, AMERICAS, EUROPE
Organisation: 
360IRESEARCH
Summary
Key Points: 
  • The extracorporeal membrane oxygenation (ECMO) machine, a crucial medical device, offers extended cardiac and respiratory support to patients with insufficient gas exchange capabilities, marking a significant advancement in critical care.
  • Furthermore, market prospects include integrating ECMO with other extracorporeal treatments and concentrated research efforts to expand usage indications.
  • We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Extracorporeal Membrane Oxygenation Machine Market.
  • "Dive into the Extracorporeal Membrane Oxygenation Machine Market Landscape: Explore 196 Pages of Insights, 474 Tables, and 26 Figures"




Extracorporeal Membrane Oxygenation Machine Market Projected to Reach $1,085.63 million by 2030 - Exclusive Report by 360iResearch

PUNE, India, March 13, 2024 /PRNewswire/ -- The report titled "Extracorporeal Membrane Oxygenation Machine Market by Modality (Arteriovenous ECMO, Venoarterial ECMO, Venovenous ECMO), Age (Adult, Neonate, Pediatric), Component, Application, End-User - Global Forecast 2024-2030" is now available on 360iResearch.com's offering, presents an analysis indicating that the market projected to grow from a size of $794.86 million in 2023 to reach $1,085.63 million by 2030, at a CAGR of 4.55% over the forecast period.

360iResearch

"Innovations and Global Adoption Propel ECMO Machines Market Forward Amidst Healthcare Challenges"

The extracorporeal membrane oxygenation (ECMO) machine, a crucial medical device, offers extended cardiac and respiratory support to patients with insufficient gas exchange capabilities, marking a significant advancement in critical care. ECMO machines play a pivotal role in sustaining life during severe heart and lung dysfunction, allowing these vital organs to recover by oxygenating blood outside the body and removing carbon dioxide. The increasing incidence of cardiovascular and respiratory ailments and technological improvements highlight the growing reliance on ECMO systems worldwide. Ongoing enhancements in machine design for better portability and compatibility with various treatment environments are broadening the scope for ECMO applications regardless of the challenges, such as high operational costs and a scarcity of trained personnel. Furthermore, market prospects include integrating ECMO with other extracorporeal treatments and concentrated research efforts to expand usage indications. Regionally, the Americas have significant ECMO deployment, driven by robust healthcare infrastructure, skilled workforce availability, and increased ECMO use during the COVID-19 crisis. In Europe, rising healthcare spending and an aging population increase the demand, while the Asia-Pacific region depicts significant growth due to economic advancement, increased healthcare investments, and a burgeoning medical tourism sector. This innovation, regional adoption, and strategic advancements position the ECMO machines market on a sustained growth trajectory and vital support in healthcare delivery.

Download Sample Report @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine

"Enhancing Neonatal Care: The Strategic Expansion of ECMO Centers"

The medical community is increasingly adopting extracorporeal membrane oxygenation (ECMO) technology, a critical lifesaver for infants unresponsive to traditional treatments for addressing severe neonatal respiratory and cardiac failures. This advanced support mechanism is especially vital for newborns grappling with acute conditions such as persistent pulmonary hypertension (PPHN), meconium aspiration syndrome, and severe respiratory distress, providing essential oxygenation and circulation to sustain life during critical periods. Significant technological advancements have made ECMO machines more adaptable to neonates' unique needs, facilitating broader implementation in neonatal care. Moreover, the post-COVID-19 landscape has highlighted expanding ECMO capacity as a core element of public health preparedness. These initiatives reflect a growing acknowledgment of ECMO's critical role in neonatal care and the concerted efforts to enhance access to this lifesaving technology across new and specialized centers.

"Enhancing ECMO Therapy: Innovations in Oxygenators and Optimal Component Integration for Patient Care"

In extracorporeal membrane oxygenation (ECMO) technology, advancements include the development of durable and biocompatible oxygenators, ensuring maximal efficiency in gas exchange with minimal impact on blood cells. Integral to the ECMO system, anticoagulation mechanisms are pivotal in preventing blood clotting during its passage through the ECMO circuit. Advanced blenders enable adjustable oxygen concentration levels, addressing diverse patient requirements and achieving precision in oxygen delivery. Cannulae are essential conduits for blood flow between the ECMO machine and the patient, and they are available in various sizes and materials. Heat exchangers within the ECMO setup maintain the patient's core temperature, underscoring the necessity for circulatory temperature regulation. Continuous monitoring systems are indispensable, providing vigilant oversight of patient vitals and ECMO machine performance. The oxygenator exemplifies the forefront of innovation and is designed to enhance gas exchange efficiency and reduce blood trauma. Pumps, whether centrifugal or roller, propel blood through the ECMO circuit. Centrifugal pumps are distinguished by their reduced hemolysis rates, whereas roller pumps are recognized for their simplicity and cost-efficiency. These components highlight the evolving landscape of ECMO therapy, aiming to offer personalized and effective support for patients in critical care.

Request Analyst Support @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine

"Getinge AB at the Forefront of Extracorporeal Membrane Oxygenation Machine Market with a Strong 28.07% Market Share"

The key players in the Extracorporeal Membrane Oxygenation Machine Market include Dragerwerk AG & Co. KGaA, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, Getinge AB, LivaNova PLC, Medtronic PLC, and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.

"Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Extracorporeal Membrane Oxygenation Machine Market"

We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Extracorporeal Membrane Oxygenation Machine Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Extracorporeal Membrane Oxygenation Machine Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.

Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine

"Dive into the Extracorporeal Membrane Oxygenation Machine Market Landscape: Explore 196 Pages of Insights, 474 Tables, and 26 Figures"

  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Extracorporeal Membrane Oxygenation Machine Market, by Modality
  7. Extracorporeal Membrane Oxygenation Machine Market, by Age
  8. Extracorporeal Membrane Oxygenation Machine Market, by Component
  9. Extracorporeal Membrane Oxygenation Machine Market, by Application
  10. Extracorporeal Membrane Oxygenation Machine Market, by End-User
  11. Americas Extracorporeal Membrane Oxygenation Machine Market
  12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market
  13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market
  14. Competitive Landscape
  15. Competitive Portfolio

Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/extracorporeal-membrane-oxygenation-machine

Related Reports:

  1. Extracorporeal CO2 Removal Devices Market - Global Forecast 2024-2030
  2. Extracorporeal Shock Wave Lithotripsy Market - Global Forecast 2024-2030
  3. Lithotripsy Devices Market - Global Forecast 2024-2030

About 360iResearch

Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.

We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.

Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.

Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.

Contact 360iResearch

Mr. Ketan Rohom

360iResearch Private Limited,

Office No. 519, Nyati Empress,

Opposite Phoenix Market City,

Vimannagar, Pune, Maharashtra,

India - 411014.

Email: [email protected]

USA: +1-530-264-8485

India: +91-922-607-7550

To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.

Logo - https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/extracorporeal-membrane-oxygenation-machine-market-projected-to-reach-1-085-63-million-by-2030---exclusive-report-by-360iresearch-302088239.html



Copyright: 
2024 PR Newswire. All Rights Reserved.